Literature DB >> 1763586

[Recommendations for carrying out nuclear medicine kidney function tests with a gamma camera and computer].

H Bergmann1, A Mostbeck, K Kletter, R Nicoletti, M Oberladstätter.   

Abstract

Standardization of nuclear medicine renal studies is required in order to permit the comparison of study results of a patient obtained at different laboratories. Furthermore, standardization is a prerequisite for quality control of the analysis part of the procedure. The guidelines presented here are based on a survey carried out amongst nuclear medicine laboratories in Austria and have been edited and harmonized in a workshop organized by the Austrian Nuclear Medicine Society. The guidelines include detailed descriptions of the requirements of instrumentation, of the methods of acquisition, dosage and radiation dose of the commonly used radiopharmaceuticals and all aspects of the analysis of digital renograms. A comprehensive section deals with the determination of renal clearance from the renogram, further sections cover the usage and recommended methods of captopril renography for the diagnosis of unilateral renal artery stenosis and of the frusemide renogram for the diagnosis of nephropathy and uropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763586

Source DB:  PubMed          Journal:  Acta Med Austriaca Suppl        ISSN: 0303-8181


  3 in total

1.  Development and prospective evaluation of an automated software system for quality control of quantitative 99mTc-MAG3 renal studies.

Authors:  Russell D Folks; Ernest V Garcia; Andrew T Taylor
Journal:  J Nucl Med Technol       Date:  2007-03

2.  Quality assurance and harmonisation of nuclear medicine investigations in Europe.

Authors:  H Bergmann; E Busemann-Sokole; P W Horton
Journal:  Eur J Nucl Med       Date:  1995-05

3.  European Association of Nuclear Medicine Congress. Lausanne, Switzerland, 10-14 October 1993. Abstracts.

Authors: 
Journal:  Eur J Nucl Med       Date:  1993-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.